Brighter strengthens its financing with 5.3 MSEK through exercise of warrants.

The first exercise period for Brighter’s warrants of series TO3 is now completed. The company thereby strengthens its financing with 5.3 MSEK, representing a subscription rate of 20 % and 1,332,198 new shares.

– We are very pleased to see that so many shareholders chose to subscribe already during the first of six scheduled exercise periods, says Truls Sjöstedt, Brighter’s CEO and founder.

The subsequent five exercise periods are:

11 - 25 April 2018

11 - 25 October 2018

11 - 25 April 2019

11 - 25 October 2019

10 - 24 April 2020

Those who subscribed in this exercise period have now obtained Interim Shares. Once the registration has been completed with the Swedish Companies Registration Office, conversion of the interim shares will automatically take place without further notice to the holders. The conversion is expected to occur within approximately one week from the completed registration. The interim shares will not be listed for trading.

Through this warrant exercise the number of shares and votes in Brighter will increase by 1,332,198 to a total of 63,863,063.

For terms and conditions of the Warrants, please visit: http://brighter.se/en/investors/documents/

For more information, please contact:

Truls Sjöstedt, CEO       
Tel: +46 709 73 46 00       
Email: truls.sjostedt@brighter.se

Henrik Norström, COO       
Tel: +46 733 40 30 45       
Email: henrik.norstrom@brighter.se

About Brighter AB (publ)       
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 16:30 CET on October 30, 2017.

About Us

Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first innovative tool Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

Subscribe

Documents & Links